Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-035548

Director sold 46,763 shares at an average $60.11 ($2,811,048)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Tessier-Lavigne Marc Director 2021-05-21 Sale −37,957 $60.13 $2,282,468 2,551,102 D
Tessier-Lavigne Marc Director 2021-05-24 Sale −8,806 $60.03 $528,580 2,542,296 D
Open-market sales · 46,763 sh · avg $60.11 · $2,811,048
Loading xslF345X03/doc4.xml…